A significant proportion of human intraductal breast carcinomas (ductal carcinoma in situ) demonstrate Her-2/neu amplification/overexpression, suggesting that the functional activity of this oncogene is enhanced early in the progression of malignant breast disease. The gene discussed is ERBB2; the disease is breast carcinoma.